EE200100527A - Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks - Google Patents

Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks

Info

Publication number
EE200100527A
EE200100527A EEP200100527A EEP200100527A EE200100527A EE 200100527 A EE200100527 A EE 200100527A EE P200100527 A EEP200100527 A EE P200100527A EE P200100527 A EEP200100527 A EE P200100527A EE 200100527 A EE200100527 A EE 200100527A
Authority
EE
Estonia
Prior art keywords
osanetant
preparation
treatment
mood disorders
medicaments useful
Prior art date
Application number
EEP200100527A
Other languages
English (en)
Inventor
Emonds-Alt Xavier
Soubrie Philippe
Steinberg R�gis
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200100527A publication Critical patent/EE200100527A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
EEP200100527A 1999-04-13 2000-04-11 Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks EE200100527A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
PCT/FR2000/000924 WO2000061125A2 (fr) 1999-04-13 2000-04-11 L'osanetant dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
EE200100527A true EE200100527A (et) 2002-12-16

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100527A EE200100527A (et) 1999-04-13 2000-04-11 Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks

Country Status (24)

Country Link
US (1) US6420388B1 (et)
EP (1) EP1175215A2 (et)
JP (1) JP2002541190A (et)
KR (1) KR20010105418A (et)
CN (1) CN1354662A (et)
AR (1) AR023452A1 (et)
AU (1) AU3971600A (et)
BR (1) BR0009704A (et)
CA (1) CA2369638A1 (et)
CZ (1) CZ20013645A3 (et)
EE (1) EE200100527A (et)
FR (1) FR2792199B3 (et)
HR (1) HRP20010741A2 (et)
HU (1) HUP0200655A3 (et)
ID (1) ID30458A (et)
IS (1) IS6098A (et)
MX (1) MXPA01010340A (et)
NO (1) NO20014953L (et)
PE (1) PE20010032A1 (et)
PL (1) PL351554A1 (et)
SK (1) SK14552001A3 (et)
TR (1) TR200102930T2 (et)
WO (1) WO2000061125A2 (et)
ZA (1) ZA200108289B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
WO2005061544A2 (en) * 2003-12-22 2005-07-07 Glaxo Group Limited Nogo-a neutralising immunoglobulins for treatment of neurological diseases
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、nk3アンタゴニストの使用
EP1867717A4 (en) * 2005-03-15 2008-08-20 Sumitomo Chemical Co METHOD FOR REDUCE SYMPTOM CAUSED BY MUTUAL DISORDER
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EP1175215A2 (fr) 2002-01-30
PL351554A1 (en) 2003-05-05
TR200102930T2 (tr) 2002-04-22
CZ20013645A3 (cs) 2002-01-16
NO20014953L (no) 2001-12-11
NO20014953D0 (no) 2001-10-11
US6420388B1 (en) 2002-07-16
AU3971600A (en) 2000-11-14
FR2792199A1 (fr) 2000-10-20
IS6098A (is) 2001-09-28
ZA200108289B (en) 2002-12-24
SK14552001A3 (sk) 2002-02-05
AR023452A1 (es) 2002-09-04
CA2369638A1 (en) 2000-10-19
PE20010032A1 (es) 2001-04-11
HUP0200655A2 (hu) 2002-07-29
JP2002541190A (ja) 2002-12-03
KR20010105418A (ko) 2001-11-28
FR2792199B3 (fr) 2001-05-18
BR0009704A (pt) 2002-01-08
CN1354662A (zh) 2002-06-19
HUP0200655A3 (en) 2002-11-28
MXPA01010340A (es) 2002-05-06
ID30458A (id) 2001-12-06
WO2000061125A3 (fr) 2001-04-19
WO2000061125A2 (fr) 2000-10-19
HRP20010741A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
CY2013041I2 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
NO20021845D0 (no) Behandling av sövnforstyrrelser under anvendelse av desloratadin
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
DE60023873D1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
IS6137A (is) Meðhöndlun á hugsýkistruflunum
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20020784D0 (no) Medikament for behandling av brudd
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
NO20020008L (no) Anvendelse av cortisol antagonister i behandling av hjertesvikt
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
DE60043648D1 (de) Medikamente zur behandlung von periodontalen erkrankungen
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom